-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EK9zh9uSytU2jMsQ8D9O7tg9Eon2esg+KnuF4AGdLj40yd7RD9C7n/TOp0eDpejk
 DA/YOZV1upFP9QCTg5nKJw==

<SEC-DOCUMENT>0001297077-07-000024.txt : 20070727
<SEC-HEADER>0001297077-07-000024.hdr.sgml : 20070727
<ACCEPTANCE-DATETIME>20070727172106
ACCESSION NUMBER:		0001297077-07-000024
CONFORMED SUBMISSION TYPE:	NT 10-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070430
FILED AS OF DATE:		20070727
DATE AS OF CHANGE:		20070727
EFFECTIVENESS DATE:		20070727

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS BIOTECHNOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-EATING & DRINKING PLACES [5810]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		NT 10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17263
		FILM NUMBER:		071007547

	BUSINESS ADDRESS:	
		STREET 1:		2200 WILSON BLVD
		STREET 2:		SUITE 102-316
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22201
		BUSINESS PHONE:		703-526-0400

	MAIL ADDRESS:	
		STREET 1:		2200 WILSON BLVD.
		STREET 2:		SUITE 102-316
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-K
<SEQUENCE>1
<FILENAME>cbi12b-25_10ksb04302007.htm
<TEXT>
<html>
<head><meta content="text/html; charset=iso-8859-1">
<title>UNITED STATES</title>
</head>

<body >
<ul>
</ul>

<p align="center">
<b>UNITED STATES</b><br><b>SECURITIES AND EXCHANGE
COMMISSION</b><br><b>Washington, D.C. 20549</b><p align="center">
<b>FORM 12b-25</b><br><b>NOTIFICATION OF LATE FILING</b><p align="center">
<b>Commission File Number: 0-17263</b><p align="center">
(Check one) [X] Form 10-K and Form 10-KSB&nbsp;&nbsp;&nbsp; [ ] Form
11-K&nbsp;&nbsp;&nbsp; [ ] Form 20-F&nbsp;&nbsp;&nbsp; [&nbsp; ] Form 10-Q<br>[
] Form 10-QSB&nbsp;&nbsp;&nbsp; [ ] Form N-SAR<p align="center">
<b>For Period Ended April 30, 2007</b><p>
[ ] Transition Report on Form 10-K and Form 10-KSB<p>
[ ] Transition Report on Form 20-F<p>
[ ] Transition Report on Form 11-K<p>
[ ] Transition Report on Form 10-Q and Form 10-QSB<p>
[ ] Transition Report on Form N-SAR<p>
For Transition Period Ended:<p align="center">
Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.<br>Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.<p align="center">
If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:<p align="center">
<b>____________________________________________________________________________</b><p align="center">
<b>PART I - REGISTRANT INFORMATION</b><p align="center">
<font size="4"><b>Champions Biotechnology, Inc.</b></font><br>Full Name of
Registrant<p align="center">
Former Name if Applicable<p align="center">
<b>2200 Wilson Blvd., Suite 102-316</b><br>Address of Principal Executive Office
(Street and Number):<p align="center">
<b>Arlington, Virginia 22201</b><br>City, State and Zip Code<p align="center">
<b>____________________________________________________________________________</b></p align="center">
<div align="center" color="#000080" style="position:relative; left: -5"><b></b><hr size="3" color="#999999" STYLE="page-break-after: always"> &nbsp; </div><p>
<p align="center">
<b>PART II - RULES 12b-25(b) AND (c)</b><p>
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)<p>
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;<p>
[X] (b) The subject annual report, semi-annual report, transition report on Form
10-K, 10-KSB, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the 15<sup>th</sup> calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q, 10-QSB, or
portion thereof will be filed on or before the fifth calendar day following the
prescribed due date; and<p>
[&nbsp;&nbsp;&nbsp;] (c) The accountants statement or other exhibit required by
Rule 12b-25(c) has been attached if applicable.<p align="center">
_____________________________________________________________________________________________<p align="center">
<b>PART III - NARRATIVE</b><p>
State below in reasonable detail the reasons why Form 10-K, 10-KSB, 11-K, 20-F,
10-Q, 10-QSB, N-SAR, or the transition report or portion thereof could not be
filed within the prescribed period. (Attach extra sheets if needed.)<p>
The Registrant&#8217;s&nbsp;annual report on Form 10-KSB could not be filed
within the prescribed time period because its auditors need additional time to
complete their review of the audited financial statements of the Registrant for
the year ended April 30, 2007. Such delay could not be eliminated by the Company
without unreasonable effort and expense. In accordance with Rule 12b-25 of the
Securities Exchange Act of 1934, the Company will file its Form 10-KSB no later
than&nbsp;fifteen calendar days following the prescribed due
date.<p align="center">
_____________________________________________________________________________________________</p>
&nbsp;	<p align="center">
<b>PART IV - OTHER INFORMATION</b></p>
&nbsp;(1) Name and telephone number of person to contact in regard to this notification	<p align="center">
James Martell&nbsp;&nbsp;&nbsp; (703) 526-0400<br>(Name) (Area Code) (Telephone
Number)<p>
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).<p>
[X] Yes&nbsp;&nbsp;[&nbsp;&nbsp;] No<p>
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof:<p>
[&nbsp;&nbsp;] Yes [X] No<p>
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.</p align="center">
<div align="center" color="#000080" style="position:relative; left: -5"><b>2</b><hr size="3" color="#999999" STYLE="page-break-after: always"> &nbsp; </div><p>
<p align="center">
<b>Champions Biotechnology, Inc.</b><br>(Name of Registrant as Specified in
Charter)<p>
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.</p>
&nbsp;	<div style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="383.999904" colspan="1" rowspan="1" BGCOLOR=#ffffff>
&nbsp;</td>
<td width="239.999940" colspan="2" rowspan="1" BGCOLOR=#ffffff>
<p>
<b>Champions Biotechnology, Inc.</b></p>
</td>
</tr>
<tr valign="top">
<td width="383.999904" colspan="1" rowspan="1" BGCOLOR=#ffffff>
&nbsp;</td>
<td width="239.999940" colspan="2" rowspan="1" BGCOLOR=#ffffff>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="383.999904" colspan="1" rowspan="1" BGCOLOR=#ffffff>
&nbsp;</td>
<td width="239.999940" colspan="2" rowspan="1" BGCOLOR=#ffffff>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="383.999904" colspan="1" rowspan="1" BGCOLOR=#ffffff>
<p>
Date: July 27, 2007</p>
</td>
<td width="35.999991" colspan="1" rowspan="1" BGCOLOR=#ffffff>
<p>
By:&nbsp;&nbsp;</p>
</td>
<td width="203.999949" colspan="1" rowspan="1" BGCOLOR=#ffffff>
<p style="border-bottom:solid windowtext .5pt">
<font size="3">/s/&nbsp;James Martell</font></p>
</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="2" rowspan="1" BGCOLOR=#ffffff>
&nbsp;</td>
<td width="203.999949" colspan="1" rowspan="1" BGCOLOR=#ffffff>
<p>
James Martell</p>
</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="2" rowspan="1" BGCOLOR=#ffffff>
&nbsp;</td>
<td width="203.999949" colspan="1" rowspan="1" BGCOLOR=#ffffff>
<p>
President and CEO</p>
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" color="#000080" style="position:relative; left: -5"><b>3</b><hr size="3" color="#999999" STYLE="page-break-after: always"> &nbsp; </div><p>
</p>


</body>

</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
